Bill Text: IL SB1413 | 2023-2024 | 103rd General Assembly | Introduced

---

Bill Title: Creates the Sale of Pharmaceuticals on Social Media Act. Provides that, notwithstanding any other provision of law, no individual shall sell or advertise the sale of a pharmaceutical on social media unless the individual has completed a verification process with specified requirements.

Spectrum: Bipartisan Bill

Status: (Introduced) 2024-04-19 - Rule 3-9(a) / Re-referred to Assignments [SB1413 Detail]

Download: Illinois-2023-SB1413-Introduced.html

---

103RD GENERAL ASSEMBLY State of Illinois 2023 and 2024 SB1413 Introduced 2/6/2023, by Sen. Sue Rezin SYNOPSIS AS INTRODUCED:
New Act
Creates the Sale of Pharmaceuticals on Social Media Act. Provides that, notwithstanding any other provision of law, no individual shall sell or advertise the sale of a pharmaceutical on social media unless the individual has completed a verification process with specified requirements.
LRB103 28324 CPF 54703 b
A BILL FOR
SB1413 LRB103 28324 CPF 54703 b
AN ACT concerning regulation.
Be it enacted by the People of the State of Illinois,
represented in the General Assembly:
Section 1. Short title. This Act may be cited as the Sale
of Pharmaceuticals on Social Media Act.
Section 5. Definition. In this Act, "social media" has the
same meaning as defined in Section 6-5 of the Liquor Control
Act of 1934.
Section 10. Sale of pharmaceuticals on social media;
verification process. Notwithstanding any other provision of
law, no individual shall sell or advertise the sale of a
pharmaceutical on social media unless the individual has
completed the following verification process:
(1) the individual shall submit an image of both the
front and back of the individual's state-issued
identification card to the social media platform upon or
through which the pharmaceutical is to be sold or
advertised;
(2) a disclaimer must be included in any advertisement
for the pharmaceutical on the social media platform that
clearly discloses the name of the individual selling the
pharmaceutical;

SB1413 - 2 - LRB103 28324 CPF 54703 b
(3) the individual must be identified on the social
media page upon which the pharmaceutical is being sold or
advertised; and
(4) the individual must display a disclaimer on the
individual's main page on the social media platform
stating that the owner or operator sells or advertises the
pharmaceutical on that social media platform.